| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human PHYHIPL recombinant protein (Position: M1-D336) was used as the immunogen for the PHYHIPL antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
PHYHIPL Antibody / Phytanoyl-CoA hydroxylase-interacting protein-like is a anti-PHYHIPL Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as Western blot (WB), ELISA with listed reactivity in Human, Mouse, Rat.
Key elements and design rationale
- Target: PHYHIPL
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): WB, ELISA
Biological background
PHYHIPL is encoded by the PHYHIPL gene located on human chromosome 10p12.2. The protein is approximately 148 amino acids long and shows sequence similarity to PHYHIP, which interacts with phytanoyl-CoA hydroxylase, an enzyme involved in alpha-oxidation of branched-chain fatty acids. PHYHIPL is expressed in the brain, liver, and heart, suggesting a broader metabolic role than its paralog.
The PHYHIPL antibody detects a 16 kilodalton protein by western blot and displays diffuse cytoplasmic staining under immunofluorescence microscopy. Although the functional data are limited, PHYHIPL has been linked to neuronal differentiation, axonal growth, and synaptic organization through proteomic analyses. It may serve as an adaptor or scaffolding molecule connecting lipid metabolism enzymes with cytoskeletal or signaling components.
Transcriptomic studies reveal that PHYHIPL expression is enriched in developing neural tissues and reduced in neurodegenerative diseases, indicating potential roles in brain maturation and protection. It has also been identified as a candidate biomarker in studies of metabolic syndromes and cardiovascular disease due to altered expression in lipid-related pathways.
Because PHYHIPL likely integrates metabolic and neuronal processes, it serves as a promising research target for understanding how lipid metabolism supports neural function.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
